Integra Life Sciences Biologic Mesh Recall Lawsuit Criteria
The recall of these products, issued in May 2023, was due to manufacturing issues that failed to remove bacteria and their endotoxins from the collagen-based mesh. The company has received warning letters and FDA deficiencies regarding its Quality Management Systems.
Eligibility Criteria
To determine eligibility for a lawsuit related to Integra Life Sciences Biologic Mesh, consider the following criteria:
- Biologic Mesh Implant Date: The implantation of the biologic mesh must have occurred in 2016 or later.
- Specific Products: We are specifically looking for cases involving SurgiMend, ReVize, PriMatrix, and TissueMend. These products are not limited to hernia repair and may have been used for various indications.
- Serious Infections: Cases involving serious infections requiring hospitalization or resulting in death are of particular interest. Specific infections include sepsis, septic shock, meningitis, pulmonary infection, and implant rejection requiring removal.
- Medical Records: If medical records demonstrate a less severe injury caused by one of the qualifying mesh products and confirm proof of the mesh leading to the injury, the case will be evaluated.
Contact Information
For more information or to discuss your case eligibility, please contact us at (251) 200-5382.
